Publications:
- Overcoming Challenges to Formulation Development for Pediatric Medicines. Challenger C, Worthington J (Contributing Author). Pharmaceutical Technology. 47.8 (August 2023) 20-25.
- It’s a Matter of Taste-Masking. Thomas F, Tisi D (Contributing Author). Pharmaceutical Technology. 45.12 (December 2021) 26-28.
- Avoiding Bitter Taste. Thomas F, Tisi D (Contributing Author). Pharmaceutical Technology. 43.11 (November 2019) 26-29.
- Development and Palatability Assessment of Norvir® (Ritonavir) 100 mg Powder for Pediatric Population. Morris JB, Tisi DA, Tan DC, Worthington JH. Int. J. Mol. Sci. (2019) 20(7): 1718
- Evaluation of Physical Characteristics of Dexlansoprazole Orally Disintegrating Tablets. Nudurupati SV Et. al. Pharmaceutical Technology 42.8 (August 2018) 30-37.
- Tisi DA. (2017). Development of Palatable Drug Formulations using Discrete Time Intensity Sensory Methodology In Hort J et. al (Ed.). Time-Dependent Measures of Perception in Sensory Evaluation (pp. 210). West Sussex, UK: Wiley Blackwell.
- Growing Demand for Taste-Masking Technologies. Challenger C, Worthington J. Pharmaceutical Technology 41.11 (November 2017) 24-27.
- Developing Palatable Drug Products: A Decision Framework and Guide for CDMOs. Worthington J, Tisi D. Contract Pharma March (2016) 32-36.
- A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms. Zajicek A, Worthington J, et. al. The AAPS Journal 15.4 (2013) 1072-1081.
- An Investigation of the Relationship Between Eszopiclone Tablet Coating and Initial Perception of Bitterness Using the Flavor Profile Method. Tisi DA, Worthington JH, Hsia R, Saranteas K, Schaefer K. Tablets and Capsules 9.7 (2011): 10-16.
- Pediatric Formulations: Technical and Regulatory Considerations. Worthington JH, Tisi DA, Lum S, Chow K. Pharmaceutical Technology Supplement 33.8 (2009): 58-67.
- The Taste of Success. Tisi DA. Pharmaceutical Formulation and Quality 11.2 (2009): 14-18.
- Evaluation of a Taste Sensor Instrument (Electronic Tongue) for use in Formulation Development. Lorenz JK, Reo JP, Hendl O, Worthington JH, Petrossian VD. International Journal of Pharmaceutics 367 (2009): 65-72.
- Sensory-Directed Formulations. Worthington JH, Tisi DA, Blondino FE, Opawale FO. Drug Delivery Technology 8.9 (2008): 68-73.
- Formulation – Let’s Talk About Sense Appeal. Worthington JH. Pharmaceutical Formulation and Quality 9.6 (2007): 32-38.
- Palatable Formulations. Worthington JH, Tisi DA. Drug Delivery Technology 7.9 (2007): 67-71.
- Drug Delivery Executive Forum. Worthington JH. Drug Delivery Technology 7.7 (2007): 52-54.
- Helping the Medicine Go Down. Worthington JH. Innovations in Pharmaceutical Technology 22 (2007): 63-65.
- The Yuck Factor. Worthington JH. Pharmaceutical Formulation and Quality 9.1 (2007): 26-30.
Selected presentations by Senopsys staff include:
- Food And Drug Administration invited Speaker “Defining ‘Candy-Like’ Nonprescription Drug Products”. FDA ONPD Public Meeting. October 30, 2023
- “Selecting Excipients for Improved Drug Palatability”. ExciPerience Conference. September 14, 2023
- “Innovations and Advances in Drug Dosage Forms”. Drug Solutions Podcast. August 1, 2023
- “Taste Assessment and Optimization of Oral Formulations” October 27, 2022 NJPhAST Meeting.
- “Taste Masking as an Alternative to Improve Patient Convenience and Compliance” (BASF, Glatt & Senopsys LLC.), November, 2020 AAPS PharmSci 360 Annual Meeting.
- “Sensory Evaluation of Norvir® (Ritonavir) 100 mg Powder for Special Populations” (AbbVie Inc. & Senopsys LLC.), November, 2019 AAPS PharmSci 360 Annual Meeting.
- “The Science of Taste Perception and Sensory Analysis” (Symposia on Pediatric Drug Products), 2017 AAPS Annual Meeting – San Diego, CA. [Presentation Here]
- “Development Strategies for Age-Appropriate Pediatric Drug Products”, 2017 Joint Meeting of the Southern California Pharmaceutical Discussion Group / Southern California American Chemical Society (SCPDG/SDACS)
- “A Structured Taste Masking Process for Developing Palatable Pediatric Chewable Tablets”, 2017 Northeast Regional Discussion Group Annual Meeting
- “Developing Palatable Drug Products: It’s More than Yuck and Yum”, 2017 AAPS Bay Area Discussion Group
- “A Structured Taste Masking Process for Developing Palatable Pediatric Chewable Tablets” (Bristol-Myers Squibb), 2016 AAPS Annual Meeting.
- “Flavor Profile Method of Descriptive Sensory Analys Development of a Solithromycin Pediatric Powder for Oral Suspension Formulation” (Cempra Inc. & Toyama Chemical Co., Ltd), 2015 AAPS Annual Meeting.
- “Developing Palatable Pediatric Formulations”, Pediatric Formulations Development Workshop, ACCP Annual Meeting September 2013.
- “Framework for Developing Palatable Paediatric Drug Products – The Tools and Approaches for Taste Masking” Global Research in Paediatrics (GRiP) 4th “Meet the Expert” on Paediatric Formulations, June 2013.
- “Development of Apixaban Oral Solution Formulation: Excipients and Palatability.” (Bristol-Myers Squibb), 2013 ASCPT Annual Meeting.
- “Sensory-directed Taste Optimization of Pediatric Drug Products”(Guest Lecture), Concordia School of Pharmacy January 2013.
- “Sensory-directed Taste Optimization of Pediatric Drug Products”(Short Course), 2010 AAPS Annual Meeting.
- “Taste Effects of Excipients Used in the Solubilization of Hydrophobic Drugs”, April, 2010 AAPS Northeast Regional Discussion Group.
- “Pediatric Drug Delivery: Formulating Better Medicines for Children” (With Dr. Susan Lum of Patheon Inc.), February, 2010 New Jersey Pharmaceutical Association for Science and Technology Meeting.
- “An Investigation of the Relationship Between Eszopiclone Tablet Coating and Initial Dysgeusia Using the Flavor Profile Method” (Sepracor), 2009 AAPS Annual Meeting.
- “Development of a Palatable, Oral Solution of Tolevamer™” (Genzyme), 2006 AAPS Annual Meeting.
- “The Development of Palatable Pediatric Formulations – Establishing the Target, Measuring Progress and Verifying Acceptability,” Pre-Clinical and Clinical Strategies for Pediatric Drug Development, February 2006.
- “Developing Palatable Pharmaceuticals,” SRI Drug Delivery Technologies and Deal Making Summit, September 2005.
- “A Sensory Panel Method for Measuring the Mouthfeel Characteristics and Ease-of-swallowing of Film Coated Tablets” (Colorcon), 2004 AAPS Annual Meeting.
- “Development of a Palatable Oral Suspension Containing Tenofovir Disoproxil Fumarate” (Gilead Sciences), 2003 AAPS Annual Meeting.
- “Development of a Palatable Oral Suspension Dosage form of Cefditoren Pivoxil” (TAP Pharmaceuticals), 2002 AAPS Annual Meeting.
- “Development of a Palatable Stable Pediatric Oral Suspension Containing Emivirine” (Triangle Laboratories), 2000 AAPS Annual Meeting.
- “Development of a Palatable, Oral Liquid Drug Product for Sodium n-(8-[2-hydroxybenzoyl]-amino) caprylate (SNAC) and Heparin Sodium” (Emisphere Technologies), 1999 AAPS Annual Meeting.